Simulations Plus, Inc. (NASDAQ:NASDAQ:SLP) Q3 2022 Results Conference Call July 06, 2022 05:00 PM ET Company Participants Brian Siegel - Hayden IR Shawn O’Connor - CEO Will Frederick - CFO.
Senior Editor
The Association for Accessible Medicinesâs new economic analysis has found that delays in the approval of complex generics are costing the U.S. health care system an estimated $1.3 billion each year.
The analysis, titled âPotential Savings from Accelerating US Approval of Complex Generics,â was sponsored by Teva, and unveiled at an event, hosted by The Hill and sponsored by AAM, discussing the role of complex generics in the prescription landscape.
Complex generics, including epinephrine auto-injectors for anaphylaxis and inhalers used to manage asthma, treat chronic and serious medical conditions, such as multiple sclerosis, schizophrenia, metastatic breast cancer and diabetes.
Welcome to Friday’s Overnight Health Care.
The Biden administration is using the Defense Production Act to try to speed PPE manufacturing and COVID testing. A new CDC study shows mask mandates helped reduce hospitalizations, and President Biden is ready to move forward on coronavirus relief without Republicans.
We ll start with the White House and two new actions from the Biden administration on the pandemic:
ADVERTISEMENT
First: using the Defense Production Act to boost tests, gloves and vaccine supplies
The Biden administration will use wartime powers to significantly increase the supply of rapid at-home and point-of-care COVID-19 tests.
The Defense Production Act (DPA) will be used to “rapidly surge” domestic testing capabilities, investing money in six suppliers to produce 61 million at-home and point-of-care tests to be available by the end of the summer, said Tim Manning, the White House COVID-19 response team supply coordinator.
Welcome to Thursday s Overnight Health Care.
Johnson & Johnson filed for emergency authorization of its vaccine. Senate Democrats are pushing forward on their coronavirus relief bill, starting with an all night vote-a-rama. The Centers for Disease Control and Prevention found that members of the LGBTQ+ community are at greater risk for severe COVID-19 symptoms and Wisconsin s governor and GOP legislature are set up for a showdown over the state s mask mandate.
We ll start with J&J:
ADVERTISEMENT
Johnson & Johnson requests emergency use authorization of its COVID-19 vaccine
Some positive news on the vaccine front: Johnson & Johnson on Thursday filed an application for emergency use authorization for its single-shot coronavirus vaccine, bringing it one step closer to helping the U.S. fight the virus.